Takeda Stories

Ramona Sequeira shares her views on fostering innovation in the industry

Media event spotlights our dedication to neurodiversity

Fireside chat offers the opportunity to learn about Takeda’s bright future

Unveiling the 2022 Global CSR Program partners to strengthen health systems around the world

Latest Takeda commercial provides a glimpse into cutting-edge manufacturing and supply

Takeda’s data science team confronts the challenges of digital transformation in pharma

The world's largest flower blooms at the Takeda Garden, Kyoto for the first time in five years

Annual Shareholders Meeting: Takeda “building for the future”

Takeda’s new net-zero emissions targets for 2035 and 2040

Jefferies Healthcare Conference – A Fireside Chat with Takeda leaders

Helping kids have serious fun despite the pandemic

Advancing our manufacturing processes with a simple sketch

Safeguarding Plant Diversity for Future Generations

Rethinking Rare: Rare Disease Day 2022

Learn more

Training health workers to reach remote communities

Evi found a team who makes her feel heard

Improving the health of ethnic minority women and newborns in Asia

Connecting with retail investors at Nomura IR Asset Management Fair 2022

J.P. Morgan Healthcare Conference: Why we’re positioned for growth over the next decade

Balancing work and athletics, Takeda team competes in New Year Ekiden

Honoring our Japanese heritage and advancing efforts to fight COVID-19

Innovation is key to sustaining our business

An environment in which LGBTQ+ employees can work with pride

Takeda celebrates turning 240

Takeda’s Partnership Strategy is Advancing the Fight Against Cancer

Share buyback program signals confidence in business strategy

PDT is transforming the lives of patients

Takeda’s Global CSR Program

Telling Takeda’s story to retail investors

Leader Interview: FDA approval of mobocertinib

Staying on course to transform lives, by Christophe Weber, President and CEO